MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer Research
4.9 (422) · $ 10.99 · In stock
MC0704 is a STAT3 inhibitor (IC50=2.13 μM), which can be used for the research of metastatic triple-negative breast cancer (mTNBC).
Targeting oncogenic vulnerabilities in triple negative breast
The novel STAT3 inhibitor WZ-2-033 causes regression of human
NG25, a Dual Inhibitor of TAK1 and MAP4K2, Enhances Doxorubicin-mediated Apoptosis in Breast Cancer
Frontiers Targeted Therapeutic Strategies for Triple-Negative
Frontiers Targeted Therapeutic Strategies for Triple-Negative
PX-12 is an Irreversible Inhibitor of Thioredoxin-1 (Trx-1
Ganetespib (STA-9090) is a HSP90 Inhibitor
Palbociclib is an Orally Active CDK4 and CDK6 Inhibitor for Cancer
PHT-7.3 is a Selective Inhibitor of Connector Enhancer of Kinase Suppressor of Ras 1 (Cnk1)
CCI-007 Possesses Anti-Cancer Activity against Infant MLL-Rearranged Leukemia
